Complications of K-Wire Fixation in Procedures Involving the Hand and Wrist

Lawrence P. Hsu, Edric G. Schwartz, David M. Kalainov, +2

The Journal Of Hand Surgery

Limb ReconstructionK-wire FixationHand TraumaSurgical StabilizationSurgery +5

The Operative Treatment of Peroneal Nerve Palsy*

Michael A. Mont, A. Lee Dellon, Franklin Chen, +3

Journal of Bone and Joint Surgery

Management of Tibial Defects in Total Knee Arthroplasty A Biomechanical Study

Franklin Chen, Kenneth A. Krackow

Clinical Orthopaedics and Related Research

Regenerative MedicinePeripheral DeficienciesOblique Wedge DefectBiomechanicsBone Remodeling +13

Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced unresectable mesothelioma from the JAVELIN solid tumor phase Ib trial: Safety, clinical activity, and PD-L1 expression.

Raffit Hassan, Anish Thomas, Manish R. Patel, +14

Journal of Clinical Oncology

Tumoral PathologyAdvanced Unresectable MesotheliomaPd-l1 ExpressionPd-l1– PtsMedicine +12

Nivolumab in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): Long-term survival according to prior line of treatment from CheckMate-142.

Michael J. Overman, Francesca Bergamo, Ray McDermott, +14

Journal of Clinical Oncology

Dmmr/msi-h McrcCancer ManagementPathologyLong-term SurvivalPharmacotherapy +17

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis, +272

The Lancet Haematology

Hematological MalignancyOncologyTransplantationHematologyClinical Trials +6

Nivolumab (NIVO) ± ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Five-year follow-up from CheckMate 142.

Michael J. Overman, Heinz‐Josef Lenz, Thierry André, +17

Journal of Clinical Oncology

Checkmate 142PathologyPharmacotherapyImmunotherapyLogistic Analysis +20

Using Handheld Devices for Tests in Classes

Franklin Chen, Brad A. Myers, David Yaron

Defense Technical Information Center (DTIC)

Avelumab (MSB0010718C; anti-PD-L1) as a first-line treatment for patients with advanced NSCLC from the JAVELIN Solid Tumor phase 1b trial: Safety, clinical activity, and PD-L1 expression.

Claire F. Verschraegen, Franklin Chen, David R. Spigel, +11

Journal of Clinical Oncology

ImmunologyPharmacotherapyImmunotherapyClinical TrialsTumor Immunity +14

Revision of the ununited one-bone forearm

Franklin Chen, Randall W. Culp, Lawrence H. Schneider, +1

The Journal Of Hand Surgery

Hand TraumaUnunited One-bone ForearmSurgeryAnatomyHand Surgery +2